Jun Wan

Indiana University Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

49h-index7.4kcitations467works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(43), DNA Repair Mechanisms(33), Acute Myeloid Leukemia Research(33), RNA modifications and cancer(33), Cancer-related gene regulation(32)

Publications466 total

Nucleoplasmic ZNF467 condensates boost hematopoietic stem cell engraftment via ICAM1-mediated mechanical reprogramming
Blood·2026Open Access
A sonopiezoresponse COF-based smart nanoreactor orchestrating in situ bioorthogonal chemistry and cuproptosis for enhanced tumor piezocatalytic therapy
2026Open Access
RABEP1 regulates neutrophil migration via endosomal recycling and actin polymerization
Journal of Leukocyte Biology·2026
Effects of multivitamin combined with magnesium sulfate versus magnesium sulfate alone on hemodynamics, coagulation, and maternal-infant outcomes in preeclampsia: a randomized controlled study
Journal of Health Population and Nutrition·2025Open Access
Afg3l2 couples mitochondrial vitamin B12 trafficking to amino acid metabolism to safeguard hematopoietic stem cell homeostasis
Cell Reports·2025· 1 citedOpen Access
Targeting APE1 endonuclease activity impairs metastasis and enhances genotoxic therapy response in pancreatic cancer
2025Open Access
Multi-parameter, high-resolution grating demodulation technology based on dual-wavelength differential demodulation
2025
Table S4 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S1 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S11 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S12 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S3 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S8 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S9 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Supplementary Data from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S5 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S6 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S14 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S2 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
Table S15 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025Open Access
page 1 of 24Next →

Frequent Co-authors

Jiang Qian(16), Sheng Liu(14), Heng Zhu(7), Donald J. Zack(6), Xiongbin Lu(6), Yujing Li(5), Shuli Xia(4), Kevin Van der Jeught(4), Yunlong Liu(4), Shuyi Fang(4), Yijing Su(3), Qifeng Song(3), Guo‐li Ming(3), Hongjun Song(3), Verity F. Oliver(3), Guohua Wang(3), Shannath L. Merbs(3), Chun Zhang(3), Jian Zi(3), Xiaoming He(3)